Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UPJOHN, ROBINS AND SCHERING WIN BACK SOME LOST GROUND; INDEX FALTERS

Executive Summary

Rebounding Upjohn (up 2-5/8 to 115-3/4), Robins (up 2 to 12-1/8) and Schering (up 1-3/4to 49-3/4) were the leaders on the "F-D-C" Index as drug/diversified stocks continued to head south during the week ended August 2. The three drug firms had been among several big losers the previous week. Robins had lost 8-1/4 points after the company suggested that Chapter 11 might be an answer to its Dalkon Shield litigation problems. Upjohn had fallen 5-3/4 the week ending July 26 after slipping several points the previous week, while Schering had slid 4-1/8. Chart omitted.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS008752

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel